Using an anti–TIM-3 blocking Ab, we observed that TIM-3 inhibition enhanced the survival of leukemia-bearing mice after allo-HCT and reduced exhausted TIM-3+PD-1+ (where PD-1 indicates programmed cell death protein 1) Tc frequencies. This evidence concerns the gene HAVCR2 and leukemia.